These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 5615694)

  • 1. [Accelerated excretion of beryllium with phosphicin].
    Arkhipova OG; Medved' TIa; Rudomino MV; Kabachnik MI
    Gig Tr Prof Zabol; 1967 Mar; 11(3):19-23. PubMed ID: 5615694
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of phosphoorganic complexons on the activity of alkaline phosphatase in beryllium poisoning].
    Arkhipova OG; Demokidova NK
    Farmakol Toksikol; 1967; 30(3):352-6. PubMed ID: 4970461
    [No Abstract]   [Full Text] [Related]  

  • 3. [On the protective action of phosphororganic complexons in poisoning due to soluble compounds of beryllium].
    Arkhipova OG; Dvizhkov PP; Kochetkova TA; Ivanova AS
    Gig Sanit; 1968 May; 33(5):26-31. PubMed ID: 5731603
    [No Abstract]   [Full Text] [Related]  

  • 4. Antidotes for acute beryllium sulfate intoxication in mice.
    Basinger MA; Johnson JE; Burka LT; Jones MM
    Res Commun Chem Pathol Pharmacol; 1982 Jun; 36(3):519-22. PubMed ID: 7122994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mobilization and distribution of beryllium over the course of chelation therapy with some polyaminocarboxylic acids in the rat.
    Mathur S; Flora SJ; Mathur R; Das Gupta S
    Hum Exp Toxicol; 1993 Jan; 12(1):19-24. PubMed ID: 8094965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative effectiveness of Tiron (4,5-dihydroxy benzene 1,3-disulphonic acid disodium salt) and CaNa2EDTA with time after beryllium poisoning.
    Sharma P; Shukla S
    Indian J Exp Biol; 2000 Aug; 38(8):785-90. PubMed ID: 12557911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beryllium-induced toxicity and its prevention by treatment with chelating agents.
    Sharma P; Johri S; Shukla S
    J Appl Toxicol; 2000; 20(4):313-8. PubMed ID: 10942906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Mechanisms of action of ethylenediamine-bis-isopropyl phosphinic acid disodium salt (phosphicin)].
    Arkhipova OG; Medved' TIa; Rudomino MV; Kabachnik MI
    Gig Tr Prof Zabol; 1965 Jan; 9(1):46-9. PubMed ID: 4143779
    [No Abstract]   [Full Text] [Related]  

  • 9. Screening of new chelating agents for beryllium. AMRL-TR-65-135.
    Sterner W; Loveless LE
    AMRL TR; 1965 Sep; ():1-22. PubMed ID: 5294713
    [No Abstract]   [Full Text] [Related]  

  • 10. Hygienic and toxicological aspects of occupational and environmental exposure to beryllium.
    Bencko V; Vasil'eva EV
    J Hyg Epidemiol Microbiol Immunol; 1983; 27(4):403-17. PubMed ID: 6663073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Status of protein metabolism in experimental berylliosis].
    Pavlova IV; Kharlamova SF; Kyrysheva NG
    Gig Tr Prof Zabol; 1970 May; 14(5):56-7. PubMed ID: 5428373
    [No Abstract]   [Full Text] [Related]  

  • 12. [Metabolic kinetics, distribution and elimination of beryllium from the body].
    Zhuravlve VF; Bugryshev PF
    Gig Sanit; 1974 Oct; (10):74-7. PubMed ID: 4618827
    [No Abstract]   [Full Text] [Related]  

  • 13. Use of proliferation tests to evaluate the effects of complexing agents on beryllium toxicity.
    Stephan CH; Sauvé S; Fournier M; Brousseau P
    J Appl Toxicol; 2009 Jan; 29(1):27-35. PubMed ID: 18785683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of various aminoalkylenephosphonic compounds on the accumulation of radioactive beryllium in rats].
    Razumovskiĭ NO; Elatontseva NB; Rudomino MV
    Radiobiologiia; 1984; 24(2):223-7. PubMed ID: 6729066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Some progress on beryllium.
    Food Cosmet Toxicol; 1969 Jan; 7(1):83-5. PubMed ID: 4891900
    [No Abstract]   [Full Text] [Related]  

  • 16. [Elimination of radioactive beryllium from the organism under the action of complex-forming compounds].
    Arkhipova OG; Zel'tser MR; Petushkov AA
    Radiobiologiia; 1966; 6(5):754-5. PubMed ID: 5986436
    [No Abstract]   [Full Text] [Related]  

  • 17. Chronic berylliosis of the lung: report of a case.
    Chandrashekar HB; Ramesh BR; Chitra D
    Indian J Chest Dis Allied Sci; 1996; 38(1):45-8. PubMed ID: 16892748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of pathology with distribution of Be following administration of beryllium sulfate and beryllium sulfosalicylate complexes to the rat.
    Hard GC; Skilleter DN; Reiner E
    Exp Mol Pathol; 1977 Oct; 27(2):197-212. PubMed ID: 902712
    [No Abstract]   [Full Text] [Related]  

  • 19. Cytochemical study of abnormal intranuclear structures rich in beryllium.
    Berry JP; Mentre P; Hallegot P; Levi-Setti R; Galle P
    Biol Cell; 1989; 67(2):147-57. PubMed ID: 2517225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of alpha-tocopherol, propolis and piperine on therapeutic potential of tiferron against beryllium induced toxic manifestations.
    Nirala SK; Bhadauria M; Mathur R; Mathur A
    J Appl Toxicol; 2008 Jan; 28(1):44-54. PubMed ID: 17429802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.